AP2012006302A0 - Anti-trypanosome therapeutic and diagnostic applications. - Google Patents
Anti-trypanosome therapeutic and diagnostic applications.Info
- Publication number
- AP2012006302A0 AP2012006302A0 AP2012006302A AP2012006302A AP2012006302A0 AP 2012006302 A0 AP2012006302 A0 AP 2012006302A0 AP 2012006302 A AP2012006302 A AP 2012006302A AP 2012006302 A AP2012006302 A AP 2012006302A AP 2012006302 A0 AP2012006302 A0 AP 2012006302A0
- Authority
- AP
- ARIPO
- Prior art keywords
- trypanosome
- therapeutic
- diagnostic applications
- diagnostic
- applications
- Prior art date
Links
- 230000001099 anti-trypanosomal effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/005—Trypanosoma antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0958035A FR2952649B1 (fr) | 2009-11-13 | 2009-11-13 | Applications therapeutiques et diagnostiques contre les trypanosomoses animales africaines |
PCT/EP2010/067208 WO2011058055A1 (fr) | 2009-11-13 | 2010-11-10 | Applications therapeutiques et diagnostics contre les trypanosomoses |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2012006302A0 true AP2012006302A0 (en) | 2012-06-30 |
Family
ID=42310605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2012006302A AP2012006302A0 (en) | 2009-11-13 | 2010-11-10 | Anti-trypanosome therapeutic and diagnostic applications. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20130108660A1 (xx) |
EP (1) | EP2499157A1 (xx) |
CN (1) | CN102762588A (xx) |
AP (1) | AP2012006302A0 (xx) |
AU (1) | AU2010317967A1 (xx) |
BR (1) | BR112012011062A2 (xx) |
CA (1) | CA2780208A1 (xx) |
FR (1) | FR2952649B1 (xx) |
MX (1) | MX2012005409A (xx) |
WO (1) | WO2011058055A1 (xx) |
ZA (1) | ZA201203286B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105246911B (zh) * | 2013-04-12 | 2019-10-01 | 丹麦科技大学 | 用于产生唾液酸化聚糖之具有转唾液酸酶活性的突变体唾液酸酶 |
CN103278642A (zh) * | 2013-05-15 | 2013-09-04 | 广西大学 | 一种检测伊氏锥虫vsg抗原的双抗体夹心酶联免疫吸附测定试剂盒及制备方法 |
EP3215849B1 (en) * | 2014-11-06 | 2018-12-19 | Roche Diagnostics GmbH | Recombinant trypanosoma cruzi jl7 antigen variants and their use for detecting chagas disease |
EP4313132A1 (en) * | 2021-03-31 | 2024-02-07 | Vib Vzw | Vaccine compositions for trypanosomatids |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR958035A (xx) | 1950-03-02 | |||
WO1992022325A1 (en) * | 1991-06-13 | 1992-12-23 | Curtis Powell | Vaccine for and method of treating parasitic hemoflagellate protozoa |
EP1048728A1 (en) * | 1999-04-26 | 2000-11-02 | Stichting Dienst Landbouwkundig Onderzoek | Means and method for the prevention and or treatment of trypanosomosis |
WO2002019960A2 (en) * | 2000-09-06 | 2002-03-14 | Pays, Etienne | Purification, characterization and use of protective antigenic structures against trypanosomes and related parasites |
DE10258400A1 (de) | 2002-12-13 | 2004-06-24 | N.V. Nutricia | Trans-Sialidasen aus Trypanosoma congolense |
BRPI0709560A2 (pt) | 2006-03-17 | 2011-07-19 | Vib Vzw | uso de uma proteìna mutante de trans-sialidade de trypanosoma enzimaticamente inativa, e composição farmacêutica |
CN101687024A (zh) | 2007-04-28 | 2010-03-31 | 美国弗劳恩霍夫股份有限公司 | 锥虫抗原、疫苗组合物和相关方法 |
-
2009
- 2009-11-13 FR FR0958035A patent/FR2952649B1/fr not_active Expired - Fee Related
-
2010
- 2010-11-10 CN CN2010800514325A patent/CN102762588A/zh active Pending
- 2010-11-10 US US13/509,389 patent/US20130108660A1/en not_active Abandoned
- 2010-11-10 AP AP2012006302A patent/AP2012006302A0/xx unknown
- 2010-11-10 EP EP10779306A patent/EP2499157A1/fr not_active Withdrawn
- 2010-11-10 MX MX2012005409A patent/MX2012005409A/es not_active Application Discontinuation
- 2010-11-10 AU AU2010317967A patent/AU2010317967A1/en not_active Abandoned
- 2010-11-10 BR BR112012011062A patent/BR112012011062A2/pt not_active IP Right Cessation
- 2010-11-10 CA CA2780208A patent/CA2780208A1/en not_active Abandoned
- 2010-11-10 WO PCT/EP2010/067208 patent/WO2011058055A1/fr active Application Filing
-
2012
- 2012-05-07 ZA ZA2012/03286A patent/ZA201203286B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN102762588A (zh) | 2012-10-31 |
FR2952649A1 (fr) | 2011-05-20 |
US20130108660A1 (en) | 2013-05-02 |
CA2780208A1 (en) | 2011-05-19 |
MX2012005409A (es) | 2013-03-07 |
WO2011058055A1 (fr) | 2011-05-19 |
EP2499157A1 (fr) | 2012-09-19 |
AU2010317967A1 (en) | 2012-06-21 |
FR2952649B1 (fr) | 2012-05-04 |
BR112012011062A2 (pt) | 2019-09-24 |
ZA201203286B (en) | 2013-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1171792A1 (zh) | 診斷裝置和相關方法 | |
IL216955A0 (en) | Medical devices and methods | |
GB2456813B (en) | Diagnostic context construction and comparison | |
EP2468203A4 (en) | MEDICAL DEVICE | |
SG10201403797PA (en) | Medical device assembly | |
EP2471437A4 (en) | MEDICAL DEVICE | |
EP2471435A4 (en) | MEDICAL DEVICE | |
EP2299904A4 (en) | MEDICAL DIAGNOSTIC DEVICES AND METHODS | |
EP2404540A4 (en) | MEDICAL DEVICE | |
GB0922085D0 (en) | Cancer diagnosis and treatment | |
EP2481355A4 (en) | MEDICAL DEVICE | |
IL219055A0 (en) | Medical devices and pumps therefor | |
GB0918392D0 (en) | Diagnostic and therapeutic methods | |
EP2398523A4 (en) | MEDICAL DEVICES WITH ACTIVATED SURFACES | |
EP2515972A4 (en) | MEDICAL DEVICE | |
EP2398524A4 (en) | MEDICAL DEVICES WITH ACTIVATED SURFACES | |
EP2561794A4 (en) | CONTROL SECTION OF AN ENDOSCOPE, AND ENDOSCOPE | |
EP2412288A4 (en) | MEDICAL DEVICE | |
EP2350001A4 (en) | NEW BENZYLIDENE INDOLINOES AND THEIR MEDICAL AND DIAGNOSTIC USES | |
EP2438167A4 (en) | THERAPEUTIC AND DIAGNOSTIC MOLECULES | |
AP2012006302A0 (en) | Anti-trypanosome therapeutic and diagnostic applications. | |
GB0901837D0 (en) | Cancer diagnosis and treatment | |
EG26793A (en) | Medical Injector | |
GB0908425D0 (en) | Medical use | |
GB0915319D0 (en) | Combination medicament |